Blisters and Skin Irritation Across 280 Appalachian Trail Hikers

November 12, 2026

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured image is an AI-created illustration of a fictional activity, training or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.

Reader question: What did this exact study measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?

Study snapshot

Study element	Reported detail
Population	280 of 334 recruited adults who hiked the Appalachian Trail for at least seven days; respondents contributed 38,940 wilderness-exposure days.
Design	Prospective surveillance study using an end-of-hike questionnaire about injuries, illnesses, hygiene and water practices.
Comparator	Complaint frequencies were compared descriptively within the responding cohort; the abstract did not report an unexposed control group.
Timepoint	At the end of each hike in the 1997 season; mean hike duration was 140 ± 60 days.
Key result	Foot blisters were reported by 180 hikers (64%) and skin irritation by 143 (51%); 192 hikers (69%) achieved their hiking goal.
Funding/conflict context	Funding and conflict declarations were not stated in the PubMed abstract; the full paper should be consulted before drawing conclusions about sponsorship.

What was actually measured?

Foot blisters were reported by 180 hikers (64%) and skin irritation by 143 (51%); 192 hikers (69%) achieved their hiking goal.

The study counted self-reported problems among respondents, so the percentages describe this long-distance hiking cohort rather than every trail user or every exposure day.

The denominator defines the claim. People, visits, infections, episodes, isolates, feet and blisters are different analytic units. A percentage or rate using one unit cannot be silently rewritten as the percentage of people affected.

What the result does not prove

The end-of-hike questionnaire is vulnerable to recall and response bias, complaint definitions were not necessarily clinician-confirmed, and the observational design cannot identify a single cause.

Association and timing do not automatically prove individual causation. Footwear, surfaces, climate, ultraviolet exposure, hygiene, protective equipment, training load, prior conditions, referral patterns and access to care may change an estimate.

A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors’ conclusions, this interpretation or any product.

Blister boundary: These studies did not test #003. Footwear, fit, friction, moisture, terrain and medical care are separate from cosmetic moisturization.

Keep the condition categories separate

Dryness, friction injury, sunburn, dermatitis, sensitization, fungal disease and bacterial infection are not interchangeable. A moisturizer may support hydration and the moisture barrier, but it does not diagnose infection, prevent ultraviolet injury, replace medical evaluation or substitute for activity-specific prevention.

Persistent spreading redness, drainage, fever, severe pain, rapidly worsening symptoms, a suspected contagious outbreak or major loss of function warrants prompt professional assessment. Clinicians may need microscopy, culture, patch testing, skin-prick testing or other targeted evaluation depending on the question.

Activity details worth documenting

What surface, footwear, sock, glove, mat, pool, boat, uniform, animal, climate or training load preceded the change?
Where did the problem begin, and did it change during rest, travel, deployment, competition or a different facility?
Were towels, clothing, footwear, razors, equipment or showers shared, and how were high-touch surfaces cleaned?
How often was skin wet, occluded, rubbed, heated, chilled or exposed to sun?
Did the problem alter sleep, pace, attendance, training, competition, work safety or duty status?

Prevention comes before cosmetic care

Prevention should match the hazard: well-fitted and broken-in equipment, task-appropriate textiles, friction management, clean personal gear, facility hygiene, prompt showering, ultraviolet protection and timely clinical assessment. No single intervention prevents every diagnosis.

Do not share personal skin products during an outbreak and do not test workplace, sport or environmental materials directly on skin. Follow occupational-health, sports-medicine, public-health and facility instructions for contagious or exposure-related conditions.

Primary research and authoritative guidance

Where Dr. Arsy #003 fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, infection, blisters, sunburn or sensitization; relieves pain or itch; neutralizes environmental exposures; is appropriate for every person; or provides pediatric or 24-hour efficacy.

Continue the evidence series

Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace, sports, military, maritime, animal-exposure or infection-control determination.

← Back to Doctor's Notes